The global anticoagulant reversal drugs market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Anticoagulant reversal drugs come in various drug classes such as prothrombin complex concentrates, coagulation factors, monoclonal antibodies, phytonadione, and other drug classes. In addition to this, the high demand for these drugs from various end-users such as hospitals, pharmacies, retail pharmacies, and others is primarily contributing to the global market growth.
The other key factors contributing to the market growth include a surge in the global prevalence of multiple cardiovascular indications, the increase in intracranial and gastrointestinal haemorrhages, atrial fibrillation, and the constantly rising geriatric population. The mortalities registered due to these diseases too is quite high. As per the World Health Organization, each year an estimated 17.9 million people die due to cardiovascular diseases around the globe. This further indicates the share of 35% of the global mortalities. Additionally, 85% of these cardiovascular disease mortalities are registered due to heart attacks and strokes.
To Request a Sample of our Report on Global Anticoagulant Reversal Drugs Market: https://www.omrglobal.com/request-sample/anticoagulant-reversal-drugs-market
Some key players operating in the market include Pfizer Inc., Boehringer Ingelheim GmbH, CSL Behring Limited, Portola Pharmaceuticals Inc., and Octapharma AG, among others. These players are eyeing to strengthen their position in the market by adopting various strategies as mergers and acquisitions, partnerships, collaborations, new product launch and development in the existing product portfolio, and so on.
Market Coverage
· The market number available for – 2020-2027
· Base year- 2020
· Forecast period- 2021-2027
· Segment Covered
· Regions Covered- Globally
· Competitive Landscape: Pfizer Inc., Boehringer Ingelheim GmbH, CSL Behring Limited, Portola Pharmaceuticals Inc., and Octapharma AG, among others.
(Get 15% Discount on Buying this Report)
A full Report of Global Anticoagulant Reversal Drugs Market is Available at: https://www.omrglobal.com/industry-reports/anticoagulant-reversal-drugs-market
Global Anticoagulant Reversal Drugs Market by Segments
By Drug Class
• Prothrombin Complex Concentrates
• Coagulation Factors
• Monoclonal Antibodies
• Phytonadione
• Others
By End-User
• Hospital Pharmacies
• Retail Pharmacies
• Others
Global Anticoagulant Reversal Drugs Market by Region
North America
· United States
· Canada
Europe
· UK
· Germany
· Spain
· France
· Italy
· Rest of Europe
Asia-Pacific
· India
· China
· Japan
· South Korea
· Rest of APAC
Rest of the World
Reasons to buy from us –
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
(This release has been published on Global Market Post. Global Market Post is not responsible for any content included in this release.)
